Status:
ACTIVE_NOT_RECRUITING
Pro-active Genetic Testing in Kidney Transplant Patients
Lead Sponsor:
Mayo Clinic
Conditions:
Kidney Transplant
Eligibility:
All Genders
18-99 years
Brief Summary
The purpose of this study is to determine the prevalence of genetic mutations that increase the risk of cancer and other medically actionable diseases in kidney transplant patients and to assess the i...
Eligibility Criteria
Inclusion
- \- Post transplant Kidney and Kidney Pancreas recipients.
Exclusion
- Simultaneous Liver Kidney Transplant.
- Simultaneous Heart Kidney Transplant.
- Non renal transplant history.
Key Trial Info
Start Date :
March 28 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2038
Estimated Enrollment :
177 Patients enrolled
Trial Details
Trial ID
NCT05298904
Start Date
March 28 2022
End Date
March 1 2038
Last Update
December 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Arizona
Scottsdale, Arizona, United States, 85259